Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SNL Biosolutions is a South Korean biotechnology company specializing in advanced organ-on-a-chip (OOC) technologies. The company's primary focus is the development of a high-fidelity Blood-Brain Barrier (BBB) on-a-chip platform, which mimics the physiological environment of the human brain to facilitate drug discovery and toxicity testing. By providing a more accurate alternative to animal models, SNL Biosolutions aims to improve the success rate of central nervous system (CNS) drug development. Their technology is utilized for studying neurodegenerative diseases, brain tumors, and drug delivery mechanisms across the BBB.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SNL Biosolutions.